Literature DB >> 21709377

Cost-effectiveness of a health intervention program with risk reductions for getting demented: results of a Markov model in a Swedish/Finnish setting.

Yanlei Zhang1, Miia Kivipelto, Alina Solomon, Anders Wimo.   

Abstract

Risk scores based on modifiable factors have recently been developed for dementia. This study aims to estimate the cost-effectiveness of a potential preventive intervention program meant to lower the score related to increased dementia risk. Analyses were based on a Markov model adapted to Swedish circumstances. Risk score categories and risk probabilities were derived from the Cardiovascular Risk Factors, Aging and Incidence of Dementia (CAIDE) study in Finland. Figures of costs, utilities, and mortality were obtained from literature or databases. One-way sensitivity analysis and probabilistic sensitivity analysis were carried out to investigate the robustness of the model and to identify which model inputs had most impact on the results. In the base case, the usual care had a cost of 621,000 SEK and utilities of 11.8438 quality-adjusted life year (QALYs). The intervention had a cost of 599, 026 SEK and utilities of 11.8950 QALYs. The cost was 21,974 SEK lower in the intervention with 0.0511 QALYs gained over a 20 years horizon, indicating absolute dominance. The support for cost-effectiveness was insensitive to changes in the value of QALY for demented, mortality, and risk of dementia. If the intervention program was assumed to run every year, the incremental cost-effectiveness ratio did not show absolute dominance but was still under the willingness-to-pay level. The probabilistic sensitivity analysis indicated cost effectiveness in 67% of the samplings given a willingness-to-pay level of 600,000 SEK/year. This is a promising outlook for future research on preventive interventions in dementia, emphasizing the need of conducting multi-domain randomized trials.

Entities:  

Mesh:

Year:  2011        PMID: 21709377     DOI: 10.3233/JAD-2011-110065

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  9 in total

Review 1.  Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies.

Authors:  Marieke Krol; Jocé Papenburg; Job van Exel
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

2.  Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease Interventions.

Authors:  Pei-Jung Lin; Brittany D'Cruz; Ashley A Leech; Peter J Neumann; Myrlene Sanon Aigbogun; Dorothee Oberdhan; Tara A Lavelle
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

3.  Association Between Cognition, Health Related Quality of Life, and Costs in a Population at Risk for Cognitive Decline.

Authors:  Niels Janssen; Ron L Handels; Anders Wimo; Riitta Antikainen; Tiina Laatikainen; Hilkka Soininen; Timo Strandberg; Jaakko Tuomilehto; Miia Kivipelto; Silvia M A A Evers; Frans R J Verhey; Tiia Ngandu
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 4.  The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.

Authors:  Michael Sonntag; Hans-Helmut König; Alexander Konnopka
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

Review 5.  Screening for Dementia Caused by Modifiable Lifestyle Choices Using Hybrid PET/MRI.

Authors:  Frank S Prato; William F Pavlosky; Steven C Foster; Jonathan D Thiessen; Roderic P Beaujot
Journal:  J Alzheimers Dis Rep       Date:  2019-02-04

Review 6.  Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.

Authors:  Youssef H El-Hayek; Ryan E Wiley; Charles P Khoury; Ritesh P Daya; Clive Ballard; Alison R Evans; Michael Karran; José Luis Molinuevo; Matthew Norton; Alireza Atri
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 7.  Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias: A Review of Completed and Prospective Studies.

Authors:  Nicholas T Bott; Aidan Hall; Erica N Madero; Jordan M Glenn; Nami Fuseya; Joshua L Gills; Michelle Gray
Journal:  Nutrients       Date:  2019-09-19       Impact factor: 5.717

Review 8.  B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?

Authors:  Apostolos Tsiachristas; A David Smith
Journal:  Alzheimers Dement (N Y)       Date:  2016-08-11

9.  Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.

Authors:  Anders Wimo; Ron Handels; Bengt Winblad; Christopher M Black; Gunilla Johansson; Stina Salomonsson; Maria Eriksdotter; Rezaul K Khandker
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.